HIV maturation inhibitor BMS-955176 shows good safety and efficacy in phase 2a trial
START sub-studies show no differences in lung or neurocognitive function with early or later treatment
Community-based drug projects provide an alternative to compulsory detention in Asia
START sub-study shows more bone loss with earlier HIV treatment
London clinic survey shows impact of chemsex on condom and PEP use
Risk of heart attack rises with length of HIV infection, regardless of age
Harm reduction conference calls for political leadership to reform drugs policy
With EACS release, all international HIV treatment guidelines agree on when to start – for the first time since 2006
Tenofovir alafenamide single-tablet regimen shows good efficacy with improved kidney and bone safety
